Skip to main content
Premium Trial:

Request an Annual Quote

Epic Sciences Gets Phase II SBIR Grant for Lung Cancer Assay Development

NEW YORK (GenomeWeb News) – Epic Sciences today said that it has received a Phase II Small Business Innovation Research award from the National Cancer Institute and the National Institutes of Health to develop a lung cancer assay.

The test would identify and characterize circulating tumor cells in lung cancer patients.

The contract follows a Phase I SBIR grant, under which Epic developed a "clinically useful and commercially relevant method for identifying and enumerating CTCs." Under the new award, the San Diego-based firm will finalize the diagnostic test and validate it clinically in patients with suspected lung cancer.

Epic said that the Phase I and II grants together provided the firm with $1.2 million.

"The lungs are sensitive and difficult tissues to access for biopsies and, as a result, many patients lack adequate biopsy material for diagnostic testing," David Nelson, president and CEO of Epic Sciences, said in a statement. "A blood test for lung cancer could provide a better tolerated, less risky, and more effective strategy for diagnosing lung cancer patients."

Nelson also noted that the test also will be designed to characterize circulating tumor cells to help guide personalized treatment options.

Privately held Epic recently raised $13 million in a Series B financing round.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.